Phase 2 Schizophrenia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been formally diagnosed with schizophrenia according to standard psychiatric guidelines (DSM-5)
• People whose schizophrenia did not respond well to at least two different standard antipsychotic medications before trying clozapine
• People who have been taking clozapine for more than 12 weeks but have not had a satisfactory improvement in symptoms
• People whose symptom scores on two standard rating scales (PANSS and SANS) meet a minimum threshold of severity (confirm with trial site)
• People who have enough education and communication ability to take part in study assessments
• People who agree to take part and have signed a consent form

Who may not be able to join:

• People who have a diagnosis of an intellectual disability or a substance use disorder, including alcohol use disorder
• People with a history of epilepsy, significant head trauma, or serious medical or neurological conditions (other than schizophrenia) that could affect the study
• People whose routine blood or laboratory test results show clinically significant abnormalities
• People who are pregnant or currently breastfeeding
• People who would be unable to follow the study procedures and requirements

Important: Always verify eligibility with the trial site directly before applying.